Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 280 articles:
HTML format
Text format



Single Articles


    June 2018
  1. LICHSTEIN E, Sharma A
    Changing Endpoints for Heart Failure Studies.
    J Am Coll Cardiol. 2018;71:2653-2655.
    PubMed     Text format    


  2. GREENE SJ, O'Brien EC, Mentz RJ, Luo N, et al
    Home-Time After Discharge Among Patients Hospitalized With Heart Failure.
    J Am Coll Cardiol. 2018;71:2643-2652.
    PubMed     Text format     Abstract available


  3. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Text format     Abstract available


  4. FARKOUH ME, Verma S
    Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REAL.
    J Am Coll Cardiol. 2018;71:2507-2510.
    PubMed     Text format    


    May 2018
  5. VODOVAR N, Logeart D
    Similar BNP and Mortality Association in Patients With and Without Heart Failure: Any Increase Matters.
    J Am Coll Cardiol. 2018;71:2089-2091.
    PubMed     Text format    


  6. YORK MK, Gupta DK, Reynolds CF, Farber-Eger E, et al
    B-Type Natriuretic Peptide Levels and Mortality in Patients With and Without Heart Failure.
    J Am Coll Cardiol. 2018;71:2079-2088.
    PubMed     Text format     Abstract available


  7. PARK JJ, Park JB, Park JH, Cho GY, et al
    Global Longitudinal Strain to Predict Mortality in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2018;71:1947-1957.
    PubMed     Text format     Abstract available


  8. GORODESKI EZ, Goyal P, Hummel SL, Krishnaswami A, et al
    Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future.
    J Am Coll Cardiol. 2018;71:1921-1936.
    PubMed     Text format     Abstract available


    April 2018
  9. GONZALEZ A, Schelbert EB, Diez J, Butler J, et al
    Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives.
    J Am Coll Cardiol. 2018;71:1696-1706.
    PubMed     Text format     Abstract available


  10. BOFFETTA P, Malhotra J
    Impact of Heart Failure on Cancer Incidence: A Complicated Question.
    J Am Coll Cardiol. 2018;71:1511-1512.
    PubMed     Text format    


  11. SELVARAJ S, Bhatt DL, Claggett B, Djousse L, et al
    Lack of Association Between Heart Failure and Incident Cancer.
    J Am Coll Cardiol. 2018;71:1501-1510.
    PubMed     Text format     Abstract available


    March 2018
  12. PATANE S
    Value of Serial ST2 Measurements in Acute Heart Failure: miRNA Regulation and Genetic Factors.
    J Am Coll Cardiol. 2018;71:1397.
    PubMed     Text format    


  13. VAN VARK LC, Kardys I, Boersma E, Hillege HL, et al
    Reply: Value of Serial ST2 Measurements in Acute Heart Failure: miRNA Regulation and Genetic Factors.
    J Am Coll Cardiol. 2018;71:1397-1398.
    PubMed     Text format    


  14. TAYAL B, Gorcsan J 3rd, Bax JJ, Risum N, et al
    Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
    J Am Coll Cardiol. 2018;71:1325-1333.
    PubMed     Text format     Abstract available


  15. MOGENSEN UM, Kober L, McMurray JJV
    Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1188-1189.
    PubMed     Text format    


  16. CANEPA M, Bertero E, Brunelli C, Ameri P, et al
    Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1187-1188.
    PubMed     Text format    


  17. KUMMEN M, Mayerhofer CCK, Vestad B, Broch K, et al
    Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts.
    J Am Coll Cardiol. 2018;71:1184-1186.
    PubMed     Text format    


  18. GREENE SJ, Vaduganathan M, Khan MS, Bakris GL, et al
    Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2018 Mar 10. pii: S0735-1097(18)30326.
    PubMed     Text format     Abstract available


    February 2018
  19. BAJAJ NS, Patel N, Prabhu SD, Arora G, et al
    Effect of NT-proBNP-Guided Therapy on All-Cause Mortality in Chronic Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2018;71:951-952.
    PubMed     Text format    


  20. SANO S, Oshima K, Wang Y, MacLauchlan S, et al
    Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1beta/NLRP3 Inflammasome.
    J Am Coll Cardiol. 2018;71:875-886.
    PubMed     Text format     Abstract available


  21. ROCHA BML, Cunha GJL, Menezes Falcao LF
    The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach.
    J Am Coll Cardiol. 2018;71:782-793.
    PubMed     Text format     Abstract available


  22. BORNE Y, Gransbo K, Nilsson J, Melander O, et al
    Vascular Endothelial Growth Factor D, Pulmonary Congestion, and Incidence of Heart Failure.
    J Am Coll Cardiol. 2018;71:580-582.
    PubMed     Text format    


    January 2018
  23. O'CONNOR CM, Psotka MA, Fiuzat M, Lindenfeld J, et al
    Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory.
    J Am Coll Cardiol. 2018;71:443-453.
    PubMed     Text format     Abstract available


  24. TROUGHTON RW, Frampton CMA
    Can Biomarker Panels Predict Response to Pharmacotherapy in Heart Failure?
    J Am Coll Cardiol. 2018;71:399-401.
    PubMed     Text format    


  25. OUWERKERK W, Zwinderman AH, Ng LL, Demissei B, et al
    Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
    J Am Coll Cardiol. 2018;71:386-398.
    PubMed     Text format     Abstract available


  26. QURESHI WT, Zhang ZM, Chang PP, Rosamond WD, et al
    Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
    J Am Coll Cardiol. 2018;71:1-8.
    PubMed     Text format     Abstract available


    December 2017
  27. SCHUETT K, Kleber ME, Scharnagl H, Lorkowski S, et al
    Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:3202-3204.
    PubMed     Text format    


  28. LOGSTRUP BB, Ellingsen T, Pedersen AB, Kjaersgaard A, et al
    Heart Failure and Ischemic Heart Disease in Patients With Rheumatoid Arthritis.
    J Am Coll Cardiol. 2017;70:3069-3071.
    PubMed     Text format    


  29. STEINER J, Rodes-Cabau J, Holmes DR Jr, LeWinter MM, et al
    Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:3026-3041.
    PubMed     Text format     Abstract available


  30. YANCY CW, Januzzi JL Jr, Allen LA, Butler J, et al
    2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017 Dec 13. pii: S0735-1097(17)41641.
    PubMed     Text format    


  31. MCCRINK KA, Maning J, Vu A, Jafferjee M, et al
    Cardiac betaarrestin2 Improves Contractility and Adverse Remodeling in Heart Failure, But Is Underexpressed in Humans.
    J Am Coll Cardiol. 2017;70:2948-2949.
    PubMed     Text format    


  32. FARRIS SD, Stempien-Otero A
    Reply: Could the Interplay Between Macrophages and Fibroblasts Drive Extracellular Matrix Dynamics in End-Stage Heart Failure?
    J Am Coll Cardiol. 2017;70:2838-2839.
    PubMed     Text format    


  33. DIAS NOVAES R
    Could the Interplay Between Macrophages and Fibroblasts Drive Extracellular Matrix Dynamics in End-Stage Heart Failure?
    J Am Coll Cardiol. 2017;70:2837-2838.
    PubMed     Text format    


  34. ERGLIS A, Narbute I, Poupineau M, Hovasse T, et al
    Treatment of Secondary Mitral Regurgitation in Chronic Heart Failure.
    J Am Coll Cardiol. 2017;70:2834-2835.
    PubMed     Text format    


  35. LAVIE CJ, Milani RV, Ventura HO
    Adipose Composition and Heart Failure Prognosis: Paradox or Not?
    J Am Coll Cardiol. 2017;70:2750-2751.
    PubMed     Text format    


  36. TSUJIMOTO T, Kajio H
    Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.
    J Am Coll Cardiol. 2017;70:2739-2749.
    PubMed     Text format     Abstract available


    November 2017
  37. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Text format     Abstract available


  38. REDDY YNV, Borlaug BA
    Reply: Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458-2459.
    PubMed     Text format    


  39. MESSERLI FH, Rimoldi SF, Wilhelm M
    Heart Failure With Preserved Ejection Fraction: A Late Stage of Hypertensive Heart Disease.
    J Am Coll Cardiol. 2017;70:2458.
    PubMed     Text format    


  40. BAYES-GENIS A, Nunez J, Lupon J
    Soluble ST2 for Prognosis and Monitoring in Heart Failure: The New Gold Standard?
    J Am Coll Cardiol. 2017;70:2389-2392.
    PubMed     Text format    


  41. VAN VARK LC, Lesman-Leegte I, Baart SJ, Postmus D, et al
    Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2017;70:2378-2388.
    PubMed     Text format     Abstract available


    October 2017
  42. PARIKH NI, Hall PS
    Reply: Hormone Status Correlates With Incidence of Heart Failure.
    J Am Coll Cardiol. 2017;70:2313.
    PubMed     Text format    


  43. EL-BATTRAWY I, Borggrefe M, Akin I
    Hormone Status Correlates With Incidence of Heart Failure.
    J Am Coll Cardiol. 2017;70:2312-2313.
    PubMed     Text format    


  44. STEINBERG BA, Fang JC
    Long-Term Outcomes of Acute Heart Failure: Where Are We Now?
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39762.
    PubMed     Text format    


  45. SHAH KS, Xu H, Matsouaka RA, Bhatt DL, et al
    Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
    J Am Coll Cardiol. 2017 Oct 31. pii: S0735-1097(17)39761.
    PubMed     Text format     Abstract available


  46. LEWIS GA, Schelbert EB, Williams SG, Cunnington C, et al
    Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2186-2200.
    PubMed     Text format     Abstract available


  47. PASCUAL-FIGAL DA
    Neprilysin and Heart Failure: A "Sympathetic" Relationship?
    J Am Coll Cardiol. 2017;70:2154-2156.
    PubMed     Text format    


  48. FRANCIS GS
    Cholesterol and Heart Failure: Is There an Important Connection?
    J Am Coll Cardiol. 2017;70:2137-2138.
    PubMed     Text format    


  49. BAYES-GENIS A, Nunez J, Zannad F, Ferreira JP, et al
    The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.
    J Am Coll Cardiol. 2017;70:2128-2136.
    PubMed     Text format     Abstract available


  50. POLHEMUS DJ, Trivedi RK, Gao J, Li Z, et al
    Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney.
    J Am Coll Cardiol. 2017;70:2139-2153.
    PubMed     Text format     Abstract available


  51. CARR H, Cnattingius S, Granath F, Ludvigsson JF, et al
    Reply: Preterm Birth and Risk of Heart Failure in Childhood and Early Adulthood.
    J Am Coll Cardiol. 2017;70:1944-1945.
    PubMed     Text format    


  52. BASSAREO PP, Namana V, Fanos V, Mercuro G, et al
    Preterm Birth and Risk of Heart Failure Up to Early Adulthood.
    J Am Coll Cardiol. 2017;70:1943-1944.
    PubMed     Text format    


  53. KAVALIERATOS D, Gelfman LP, Tycon LE, Riegel B, et al
    Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities.
    J Am Coll Cardiol. 2017;70:1919-1930.
    PubMed     Text format     Abstract available


  54. KLEIN L
    (Re)Discovering the Neurohormonal and Hemodynamic Duality of Heart Failure.
    J Am Coll Cardiol. 2017;70:1887-1889.
    PubMed     Text format    


  55. GIVERTZ MM, Stevenson LW, Costanzo MR, Bourge RC, et al
    Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:1875-1886.
    PubMed     Text format     Abstract available


  56. LAM PH, Dooley DJ, Deedwania P, Singh SN, et al
    Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:1861-1871.
    PubMed     Text format     Abstract available


  57. SCHERRER U, Rexhaj E, Soria R, Meister TA, et al
    Preterm Birth and Risk of Heart Failure: Potential Contribution of Assisted Reproductive Technologies.
    J Am Coll Cardiol. 2017;70:1828-1829.
    PubMed     Text format    


  58. WATANABE S, Ishikawa K, Fish K, Oh JG, et al
    Protein Phosphatase Inhibitor-1 Gene Therapy in a Swine Model of Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;70:1744-1756.
    PubMed     Text format     Abstract available


    September 2017
  59. LI JG, Xu H
    Should Beta-Blockers Be Routinely Prescribed for Myocardial Infarction Without Heart Failure or Ventricular Dysfunction?
    J Am Coll Cardiol. 2017;70:1685-1686.
    PubMed     Text format    


  60. GUAZZI M, Bandera F, Ozemek C, Systrom D, et al
    Cardiopulmonary Exercise Testing: What Is its Value?
    J Am Coll Cardiol. 2017;70:1618-1636.
    PubMed     Text format     Abstract available


  61. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    PubMed     Text format     Abstract available


  62. SIVAGNANAM K, Mendes LA, Schlendorf KH, Damp JB, et al
    Bridge to Transplantation: Advanced Heart Failure and Transplant Cardiology Training for Cardiovascular Disease Fellows.
    J Am Coll Cardiol. 2017;70:1413-1416.
    PubMed     Text format    


  63. FLORAS JS
    Ambulatory Apnea Monitoring in Heart Failure: Proceed With Caution.
    J Am Coll Cardiol. 2017;70:1365-1367.
    PubMed     Text format    


  64. EMDIN M, Mirizzi G, Giannoni A, Poletti R, et al
    Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:1351-1364.
    PubMed     Text format     Abstract available


  65. LIPSHULTZ SE, Barach PR, Wilkinson JD
    Does Lowering Heart Rate Improve Outcomes in Children With Dilated Cardiomyopathy and Chronic Heart Failure?
    J Am Coll Cardiol. 2017;70:1273-1275.
    PubMed     Text format    


  66. BONNET D, Berger F, Jokinen E, Kantor PF, et al
    Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    J Am Coll Cardiol. 2017;70:1262-1272.
    PubMed     Text format     Abstract available


    August 2017
  67. TRAVERS JG, Kamal FA, Valiente-Alandi I, Nieman ML, et al
    Pharmacological and Activated Fibroblast Targeting of Gbetagamma-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    J Am Coll Cardiol. 2017;70:958-971.
    PubMed     Text format     Abstract available


  68. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed     Text format    


  69. ONAT A, Ozbek M, Hayiroglu MI
    Rheumatoid Arthritis and Risk of Nonischemic Heart Failure: Closely Related Common Soil.
    J Am Coll Cardiol. 2017;70:687-688.
    PubMed     Text format    


    July 2017
  70. ABDULHADI B, Mezue K, Rangaswami J
    Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:408.
    PubMed     Text format    


  71. KONSTAM MA, Udelson JE
    Reply: Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
    J Am Coll Cardiol. 2017;70:408-409.
    PubMed     Text format    


  72. ABRAHAM WT, Perl L
    Implantable Hemodynamic Monitoring for Heart Failure Patients.
    J Am Coll Cardiol. 2017;70:389-398.
    PubMed     Text format     Abstract available


  73. FARRIS SD, Don C, Helterline D, Costa C, et al
    Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.
    J Am Coll Cardiol. 2017;70:344-354.
    PubMed     Text format     Abstract available


  74. ROGERS JG, Patel CB, Mentz RJ, Granger BB, et al
    Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial.
    J Am Coll Cardiol. 2017;70:331-341.
    PubMed     Text format     Abstract available


  75. BUTLER J, Skopicki H
    Quest for Pathophysiological Understanding of Heart Failure With Preserved Ejection Fraction: Stiffened Resolve, Compliant Approach.
    J Am Coll Cardiol. 2017;70:149-151.
    PubMed     Text format    


  76. REDDY YNV, Andersen MJ, Obokata M, Koepp KE, et al
    Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;70:136-148.
    PubMed     Text format     Abstract available


  77. MUNZEL T, Camici GG, Maack C, Bonetti NR, et al
    Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series.
    J Am Coll Cardiol. 2017;70:212-229.
    PubMed     Text format     Abstract available


  78. CANNAVO A, Rengo G, Liccardo D, Pun A, et al
    beta1-Blockade Prevents Post-Ischemic Myocardial Decompensation Via beta3AR-Dependent Protective Sphingosine-1 Phosphate Signaling.
    J Am Coll Cardiol. 2017;70:182-192.
    PubMed     Text format     Abstract available


    June 2017
  79. MATSUE Y, Damman K, Voors AA, Kagiyama N, et al
    Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
    J Am Coll Cardiol. 2017;69:3042-3051.
    PubMed     Text format     Abstract available


  80. SOLOMON SD, Desai AS
    Acute Heart Failure: One Syndrome or Many?
    J Am Coll Cardiol. 2017;69:3040-3041.
    PubMed     Text format    


  81. GREENE SJ, Hernandez AF, Dunning A, Ambrosy AP, et al
    Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial.
    J Am Coll Cardiol. 2017;69:3029-3039.
    PubMed     Text format     Abstract available


  82. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed     Text format    


  83. PINNEY SP, Anyanwu AC, Lala A, Teuteberg JJ, et al
    Left Ventricular Assist Devices for Lifelong Support.
    J Am Coll Cardiol. 2017;69:2845-2861.
    PubMed     Text format     Abstract available


  84. DONDO TB, Hall M, West RM, Jernberg T, et al
    beta-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
    J Am Coll Cardiol. 2017;69:2710-2720.
    PubMed     Text format     Abstract available


    May 2017
  85. LEESON P, Lewandowski AJ
    A New Risk Factor for Early Heart Failure: Preterm Birth.
    J Am Coll Cardiol. 2017;69:2643-2645.
    PubMed     Text format    


  86. CARR H, Cnattingius S, Granath F, Ludvigsson JF, et al
    Preterm Birth and Risk of Heart Failure Up to Early Adulthood.
    J Am Coll Cardiol. 2017;69:2634-2642.
    PubMed     Text format     Abstract available


  87. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Text format     Abstract available


  88. BHATT AS, DeVore AD, DeWald TA, Swedberg K, et al
    Achieving a Maximally Tolerated beta-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?
    J Am Coll Cardiol. 2017;69:2542-2550.
    PubMed     Text format     Abstract available


  89. SCOTT NS
    Understanding Hormones, Menopause, and Heart Failure: Still a Work in Progress.
    J Am Coll Cardiol. 2017;69:2527-2529.
    PubMed     Text format    


  90. HALL PS, Nah G, Howard BV, Lewis CE, et al
    Reproductive Factors and Incidence of Heart Failure Hospitalization in the Women's Health Initiative.
    J Am Coll Cardiol. 2017;69:2517-2526.
    PubMed     Text format     Abstract available


  91. HANSMANN G
    Pulmonary Hypertension in Infants, Children, and Young Adults.
    J Am Coll Cardiol. 2017;69:2551-2569.
    PubMed     Text format     Abstract available


  92. COSTANZO MR, Ronco C, Abraham WT, Agostoni P, et al
    Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research.
    J Am Coll Cardiol. 2017;69:2428-2445.
    PubMed     Text format     Abstract available


  93. ZEITLER EP, Friedman DJ, Daubert JP, Al-Khatib SM, et al
    Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;69:2369-2379.
    PubMed     Text format     Abstract available


  94. KOSMALA W, Marwick TH
    Reply: Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:2352-2353.
    PubMed     Text format    


  95. PEVERILL RE, Gelman JS
    Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:2351-2352.
    PubMed     Text format    


  96. KOSMALA W, Marwick TH
    Reply: The Influence of Exercise Therapy on the Heart Failure Disease Pathway.
    J Am Coll Cardiol. 2017;69:2351.
    PubMed     Text format    


  97. PAN A
    The Influence of Exercise Therapy on the Heart Failure Disease Pathway.
    J Am Coll Cardiol. 2017;69:2350-2351.
    PubMed     Text format    


  98. REDDY VY, Miller MA, Neuzil P, Sogaard P, et al
    Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study.
    J Am Coll Cardiol. 2017;69:2119-2129.
    PubMed     Text format     Abstract available


    April 2017
  99. YANCY CW, Jessup M, Bozkurt B, Butler J, et al
    2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of
    J Am Coll Cardiol. 2017 Apr 21. pii: S0735-1097(17)37087.
    PubMed     Text format    


  100. MENACHEM JN
    Advanced Heart Failure in the ACHD Population: Finding the Fellows' Role in a Growing Field.
    J Am Coll Cardiol. 2017;69:1986-1989.
    PubMed     Text format    


  101. JAKOVLJEVIC DG, Yacoub MH, Schueler S, MacGowan GA, et al
    Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1924-1933.
    PubMed     Text format     Abstract available


  102. ANDERSEN OS, Smiseth OA, Dokainish H, Abudiab MM, et al
    Estimating Left Ventricular Filling Pressure by Echocardiography.
    J Am Coll Cardiol. 2017;69:1937-1948.
    PubMed     Text format     Abstract available


  103. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Text format     Abstract available


  104. KOTECHA D, Flather MD, Altman DG, Holmes J, et al
    Heart Rate, Heart Rhythm, and Prognostic Benefits of Beta-Blockers in Heart Failure: Individual Patient-Data Meta-Analysis.
    J Am Coll Cardiol. 2017 Apr 5. pii: S0735-1097(17)36893.
    PubMed     Text format     Abstract available


  105. GUAZZI M, Naeije R
    Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives.
    J Am Coll Cardiol. 2017;69:1718-1734.
    PubMed     Text format     Abstract available


  106. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Text format     Abstract available


    March 2017
  107. HAVAKUK O, King KS, Grazette L, Yoon AJ, et al
    Heart Failure-Induced Brain Injury.
    J Am Coll Cardiol. 2017;69:1609-1616.
    PubMed     Text format     Abstract available


  108. FANG JC, Vidic A
    Central Sleep Apnea in Heart Failure: Sleeping With the Wrong Enemy?
    J Am Coll Cardiol. 2017;69:1588-1591.
    PubMed     Text format    


  109. O'CONNOR CM, Whellan DJ, Fiuzat M, Punjabi NM, et al
    Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.
    J Am Coll Cardiol. 2017;69:1577-1587.
    PubMed     Text format     Abstract available


  110. YANCY CW
    Acute Heart Failure: Searching for a New Evident Truth.
    J Am Coll Cardiol. 2017;69:1420-1423.
    PubMed     Text format    


  111. KONSTAM MA, Kiernan M, Chandler A, Dhingra R, et al
    Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.
    J Am Coll Cardiol. 2017;69:1409-1419.
    PubMed     Text format     Abstract available


  112. MITTER SS, Shah SJ, Thomas JD
    A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure.
    J Am Coll Cardiol. 2017;69:1451-1464.
    PubMed     Text format     Abstract available


  113. KRUMHOLZ HM, Dhruva SS
    Real World Data on Heart Failure Readmission Reduction: Real or Real Uncertain?
    J Am Coll Cardiol. 2017 Mar 15. pii: S0735-1097(17)36043.
    PubMed     Text format    


  114. HEIDENREICH P
    Inflammation and Heart Failure: Therapeutic or Diagnostic Opportunity?
    J Am Coll Cardiol. 2017;69:1286-1287.
    PubMed     Text format    


  115. MANTEL A, Holmqvist M, Andersson DC, Lund LH, et al
    Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2017;69:1275-1285.
    PubMed     Text format     Abstract available


  116. DESAI AS, Bhimaraj A, Bharmi R, Jermyn R, et al
    Reduction in Heart Failure Hospitalizations With Ambulatory Hemodynamic Monitoring Seen in Clinical Trials Is Maintained in the 'Real World'.
    J Am Coll Cardiol. 2017 Mar 9. pii: S0735-1097(17)35978.
    PubMed     Text format     Abstract available


  117. PANDEY A, LaMonte M, Klein L, Ayers C, et al
    Relationship Between Physical Activity, Body Mass Index, and Risk of Heart Failure.
    J Am Coll Cardiol. 2017;69:1129-1142.
    PubMed     Text format     Abstract available


  118. JESSUP M, Drazner MH, Book W, Cleveland JC Jr, et al
    2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac T
    J Am Coll Cardiol. 2017 Mar 3. pii: S0735-1097(17)30791.
    PubMed     Text format    


    February 2017
  119. NAGATOMO Y, McNamara DM, Alexis JD, Cooper LT, et al
    Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against beta1-Adrenergic Receptors.
    J Am Coll Cardiol. 2017;69:968-977.
    PubMed     Text format     Abstract available


  120. JANUZZI JL JR, Ibrahim NE
    Renin-Angiotensin System Blockade in Heart Failure: More to the Picture Than Meets the Eye.
    J Am Coll Cardiol. 2017;69:820-822.
    PubMed     Text format    


  121. BASU R, Poglitsch M, Yogasundaram H, Thomas J, et al
    Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.
    J Am Coll Cardiol. 2017;69:805-819.
    PubMed     Text format     Abstract available


  122. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Text format     Abstract available


  123. BAVISHI C, Bangalore S, Messerli FH
    Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients.
    J Am Coll Cardiol. 2017;69:486-493.
    PubMed     Text format     Abstract available


    January 2017
  124. GOLDSMITH SR
    Future Study With Tolvaptan in Acute Heart Failure.
    J Am Coll Cardiol. 2017;69:467.
    PubMed     Text format    


  125. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Text format     Abstract available


  126. DOSHI D, Ben-Yehuda O, Bonafede M, Josephy N, et al
    Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2017;69:364-365.
    PubMed     Text format    


  127. SHAH R
    Routine Ischemic Work-Up for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2017;69:363-364.
    PubMed     Text format    


  128. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Text format     Abstract available


  129. HINKEL R, Hoewe A, Renner S, Ng J, et al
    Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.
    J Am Coll Cardiol. 2017;69:131-143.
    PubMed     Text format     Abstract available


  130. VAN KIMMENADE RR, Ten Cate TJ, Brunner-La Rocca HP
    Worsening Renal Function in Heart Failure: It Takes 2 to Tangle.
    J Am Coll Cardiol. 2017;69:70-72.
    PubMed     Text format    


  131. NG LL, Squire IB, Jones DJ, Cao TH, et al
    Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
    J Am Coll Cardiol. 2017;69:56-69.
    PubMed     Text format     Abstract available


  132. REDDY YN, Borlaug BA
    Reply: High-Output Heart Failure: With or Without Obesity.
    J Am Coll Cardiol. 2017;69:113-114.
    PubMed     Text format    


  133. CERIT L, Kemal H, Gunsel A, Duygu H, et al
    High-Output Heart Failure: With or Without Obesity.
    J Am Coll Cardiol. 2017;69:112-113.
    PubMed     Text format    


  134. JANJUA SA, Triant VA, Addison D, Szilveszter B, et al
    HIV Infection and Heart Failure Outcomes in Women.
    J Am Coll Cardiol. 2017;69:107-108.
    PubMed     Text format    


    December 2016
  135. PAVO N, Wurm R, Goliasch G, Novak JF, et al
    Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2912-2914.
    PubMed     Text format    


  136. CARBONE S, Canada JM, Buckley LF, Trankle CR, et al
    Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2487-2488.
    PubMed     Text format    


  137. MCKIE PM, Burnett JC Jr
    NT-proBNP: The Gold Standard Biomarker in Heart Failure.
    J Am Coll Cardiol. 2016;68:2437-2439.
    PubMed     Text format    


  138. ZILE MR, Claggett BL, Prescott MF, McMurray JJ, et al
    Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
    J Am Coll Cardiol. 2016;68:2425-2436.
    PubMed     Text format     Abstract available


    November 2016
  139. KOTECHA D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, et al
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.
    J Am Coll Cardiol. 2016;68:2217-2228.
    PubMed     Text format     Abstract available


  140. HE GH, Xu GL, Cai WK, Zhang J, et al
    Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure?
    J Am Coll Cardiol. 2016;68:2029.
    PubMed     Text format    


  141. LEARY PJ, Bristow MR
    Reply: Is Histamine H2 Receptor a Real Promising Target for Prevention or Treatment of Heart Failure?
    J Am Coll Cardiol. 2016;68:2029-2030.
    PubMed     Text format    


  142. GIUSTINO G, Redfors B, Brener S, Kirtane A, et al
    TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  143. HALL S, Uriel N, Carey S, Edens M, et al
    TCT-122 Use of the Impella 5.0 circulatory support device for bridge to decision during acute decompensation of advanced heart failure.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  144. PARK Y, Rha SW, Choi BG, Byun JK, et al
    TCT-817 High-Sensitivity C-reactive Protein Predicts New-Onset Heart Failure in Patients Treated with Moderate-Intensity Statin for Primary Prevention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  145. VAN GILS L, Clavel MA, Vollema M, Delgado V, et al
    TCT-819 Clinical Outcome in Patients with Heart Failure and Moderate Aortic Stenosis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  146. ANSARI M, Garcia D
    TCT-766 Catheter-Guided Renal Denervation Used For The Treatment Of Heart Failure With Reduced Ejection Fraction: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  147. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-77 Association of Residual Mitral Regurgitation after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  148. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-665 Association of Paravalvular Leak after Transcatheter Aortic Valve Replacement with Readmission for Acute Heart Failure: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  149. PETERSEN J, Blackstone E, Rajeswaran J, Cohen D, et al
    TCT-654 Risk of Readmission for Acute Heart Failure, Subsequent Readmission, and Mortality Following Transcatheter Aortic Valve Replacement: An Analysis from PARTNER 1.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  150. STONE G, Abraham W, Lindenfeld J, Weissman N, et al
    TCT-627 Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients with Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  151. KOSMALA W, Rojek A, Przewlocka-Kosmala M, Wright L, et al
    Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;68:1823-1834.
    PubMed     Text format     Abstract available


  152. WEVER-PINZON J, Selzman CH, Stoddard G, Wever-Pinzon O, et al
    Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.
    J Am Coll Cardiol. 2016;68:1741-1752.
    PubMed     Text format     Abstract available


  153. SARWAR CM, Papadimitriou L, Pitt B, Pina I, et al
    Hyperkalemia in Heart Failure.
    J Am Coll Cardiol. 2016;68:1575-89.
    PubMed     Text format     Abstract available


  154. GUPTA SK, Foinquinos A, Thum S, Remke J, et al
    Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:1557-71.
    PubMed     Text format     Abstract available


    September 2016
  155. MAISEL AS, Wettersten N, van Veldhuisen DJ, Mueller C, et al
    Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study.
    J Am Coll Cardiol. 2016;68:1420-31.
    PubMed     Text format     Abstract available


  156. VON HAEHLING S, Hasenfuss G, Anker SD
    Diabetes and Heart Failure: Sugared Words Prove Bitter.
    J Am Coll Cardiol. 2016;68:1417-9.
    PubMed     Text format    


  157. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2016;68:1404-16.
    PubMed     Text format     Abstract available


  158. WARING AA, Litwin SE
    Redefining Reverse Remodeling: Can Echocardiography Refine Our Ability to Assess Response to Heart Failure Treatments?
    J Am Coll Cardiol. 2016;68:1277-80.
    PubMed     Text format    


  159. STARLING RC, Young JB
    Tolvaptan in Acute Heart Failure: Time to Move On.
    J Am Coll Cardiol. 2016 Sep 15. pii: S0735-1097(16)35324.
    PubMed     Text format    


  160. GIERULA J, Paton MF, Byrom R, Cubbon RM, et al
    Reply: The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1253.
    PubMed     Text format    


  161. CERIT L
    The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1252-3.
    PubMed     Text format    


  162. FELKER GM, Mentz RJ, Cole R, Adams KF, et al
    Efficacy and Safety of Tolvaptan in Patients Hospitalized with Acute Heart Failure.
    J Am Coll Cardiol. 2016 Sep 13. pii: S0735-1097(16)35321.
    PubMed     Text format     Abstract available


    August 2016
  163. KELLY JP, Hammill BG, Doll JA, Felker GM, et al
    The Potential Impact of Expanding Cardiac Rehabilitation in Heart Failure.
    J Am Coll Cardiol. 2016;68:977-8.
    PubMed     Text format    


  164. LEARY PJ, Ralph DD, Tedford RJ, Kronmal RA, et al
    Reply: Histamine H2 Receptors and Heart Failure: A Complex Cross-Talk.
    J Am Coll Cardiol. 2016;68:775-6.
    PubMed     Text format    


  165. PATANE S
    Histamine H2 Receptors and Heart Failure: A Complex Cross-Talk.
    J Am Coll Cardiol. 2016;68:774-5.
    PubMed     Text format    


  166. ANAND IS
    High-Output Heart Failure Revisited.
    J Am Coll Cardiol. 2016;68:483-6.
    PubMed     Text format    


  167. REDDY YN, Melenovsky V, Redfield MM, Nishimura RA, et al
    High-Output Heart Failure: A 15-Year Experience.
    J Am Coll Cardiol. 2016;68:473-82.
    PubMed     Text format     Abstract available


  168. YOUNG JB, Stehlik J
    Ischemic Heart Disease in New-Onset Heart Failure, or Finding Waldo: Where's Waldo?
    J Am Coll Cardiol. 2016;68:459-60.
    PubMed     Text format    


  169. DOSHI D, Ben-Yehuda O, Bonafede M, Josephy N, et al
    Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.
    J Am Coll Cardiol. 2016;68:450-8.
    PubMed     Text format     Abstract available


    July 2016
  170. OPITZ CF, Hoeper MM, Gibbs JS, Kaemmerer H, et al
    Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.
    J Am Coll Cardiol. 2016;68:368-78.
    PubMed     Text format     Abstract available


  171. MALHOTRA J, Boffetta P
    Association of Increased Cancer Risk With Heart Failure.
    J Am Coll Cardiol. 2016;68:272-3.
    PubMed     Text format    


  172. HASIN T, Gerber Y, Weston SA, Jiang R, et al
    Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.
    J Am Coll Cardiol. 2016;68:265-71.
    PubMed     Text format     Abstract available


  173. MENTZ RJ, O'Brien EC
    Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.
    J Am Coll Cardiol. 2016;68:249-51.
    PubMed     Text format    


  174. DESAI AS, Claggett BL, Packer M, Zile MR, et al
    Influence of Sacubitril/Valsartan (LCZ696) on 30-Day Readmission After Heart Failure Hospitalization.
    J Am Coll Cardiol. 2016;68:241-8.
    PubMed     Text format     Abstract available


  175. DALOS D, Mascherbauer J, Zotter-Tufaro C, Duca F, et al
    Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;68:189-99.
    PubMed     Text format     Abstract available


    June 2016
  176. SEMIGRAN MJ
    Chemotherapy to Treat Heart Failure: Appropriate for Light-Chain Amyloidosis?
    J Am Coll Cardiol. 2016;67:2949-51.
    PubMed     Text format    


  177. SPERRY BW, Ikram A, Hachamovitch R, Valent J, et al
    Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure.
    J Am Coll Cardiol. 2016;67:2941-8.
    PubMed     Text format     Abstract available


  178. SORAJJA P, Pedersen WA, Bae R, Lesser JR, et al
    First Experience With Percutaneous Mitral Valve Plication as Primary Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2016;67:2811-8.
    PubMed     Text format     Abstract available


  179. GUPTA DK, Wang TJ
    Looking for a Brighter Future in Heart Failure: A Role for Vitamin D Supplementation?
    J Am Coll Cardiol. 2016;67:2604-6.
    PubMed     Text format    


    May 2016
  180. KAYE DM, Nanayakkara S, Vizi D, Byrne M, et al
    Effects of Milrinone on Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;67:2554-6.
    PubMed     Text format    


  181. BARON SJ, Arnold SV, Herrmann HC, Holmes DR Jr, et al
    Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;67:2349-58.
    PubMed     Text format     Abstract available


  182. NAPPI F, Lusini M, Spadaccio C, Nenna A, et al
    Papillary Muscle Approximation Versus Restrictive Annuloplasty Alone for Severe Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2016;67:2334-46.
    PubMed     Text format     Abstract available


  183. EGBE AC, Luis SA, Padang R, Warnes CA, et al
    Outcomes in Moderate Mixed Aortic Valve Disease: Is it Time for a Paradigm Shift?
    J Am Coll Cardiol. 2016;67:2321-9.
    PubMed     Text format     Abstract available


  184. HANBERG JS, Sury K, Wilson FP, Brisco MA, et al
    Reduced Cardiac Index Is Not the Dominant Driver of Renal Dysfunction in Heart Failure.
    J Am Coll Cardiol. 2016;67:2199-208.
    PubMed     Text format     Abstract available


  185. YANCY CW, Jessup M, Bozkurt B, Butler J, et al
    2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Cl
    J Am Coll Cardiol. 2016 May 17. pii: S0735-1097(16)33024.
    PubMed     Text format    


  186. ANTMAN EM, Bax J, Chazal RA, Creager MA, et al
    Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.
    J Am Coll Cardiol. 2016 May 17. pii: S0735-1097(16)33025.
    PubMed     Text format    


    April 2016
  187. PITT B
    MRAs in Patients With AMI Without Early Evidence of Heart Failure: Time for Reappraisal?
    J Am Coll Cardiol. 2016;67:1928-30.
    PubMed     Text format    


  188. CHATTERJEE NA, Lewis GD
    Heart Rate Modulation in Heart Failure: Time to Slow Down?
    J Am Coll Cardiol. 2016;67:1897-900.
    PubMed     Text format    


  189. JAMIL HA, Gierula J, Paton MF, Byrom R, et al
    Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure.
    J Am Coll Cardiol. 2016;67:1885-96.
    PubMed     Text format     Abstract available


  190. BEYGUI F, Cayla G, Roule V, Roubille F, et al
    Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical Trial.
    J Am Coll Cardiol. 2016;67:1917-27.
    PubMed     Text format     Abstract available


  191. ACHARYA D, Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, et al
    Ventricular Assist Device in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:1871-80.
    PubMed     Text format     Abstract available


  192. SALERNO M, Kramer CM
    Myocardial Extracellular Volume: Unifying Form and Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;67:1826-8.
    PubMed     Text format    


  193. ROMMEL KP, von Roeder M, Latuscynski K, Oberueck C, et al
    Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;67:1815-25.
    PubMed     Text format     Abstract available


  194. VERMOND RA, Geelhoed B, Rienstra M
    Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded.
    J Am Coll Cardiol. 2016;67:1754-5.
    PubMed     Text format    


  195. ONAT A, Simsek B, Akbas T
    Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.
    J Am Coll Cardiol. 2016;67:1753-4.
    PubMed     Text format    


  196. STONE GW, Selker HP, Thiele H, Patel MR, et al
    Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.
    J Am Coll Cardiol. 2016;67:1674-83.
    PubMed     Text format     Abstract available


  197. KITAKAZE M
    Clinical Evidence of the Role of Histamine in Heart Failure.
    J Am Coll Cardiol. 2016;67:1553-5.
    PubMed     Text format    


  198. LEARY PJ, Tedford RJ, Bluemke DA, Bristow MR, et al
    Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study.
    J Am Coll Cardiol. 2016;67:1544-52.
    PubMed     Text format     Abstract available


    March 2016
  199. STARLING RC
    Cardiac Myosin Activators for the Treatment of Heart Failure: Stop Now or Push Ahead?
    J Am Coll Cardiol. 2016;67:1456-8.
    PubMed     Text format    


  200. TEERLINK JR, Felker GM, McMurray JJ, Ponikowski P, et al
    Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study.
    J Am Coll Cardiol. 2016;67:1444-55.
    PubMed     Text format     Abstract available


  201. GOLD MR, Van Veldhuisen DJ, Hauptman PJ, Borggrefe M, et al
    Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial.
    J Am Coll Cardiol. 2016 Mar 29. pii: S0735-1097(16)32404.
    PubMed     Text format     Abstract available


  202. BORLAUG BA, Koepp KE, Melenovsky V
    Reply: Nitrites/Nitrates in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;67:1383-4.
    PubMed     Text format    


  203. WEBER T, Eber B, Wassertheurer S, Hametner B, et al
    Nitrites/Nitrates in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;67:1382-3.
    PubMed     Text format    


  204. SWERDLOW CD, Kalahasty G, Ellenbogen KA
    Implantable Cardiac Defibrillator Lead Failure and Management.
    J Am Coll Cardiol. 2016;67:1358-68.
    PubMed     Text format     Abstract available


  205. ROTH GA, Poole JE, Zaha R, Zhou W, et al
    Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.
    J Am Coll Cardiol. 2016;67:1062-9.
    PubMed     Text format     Abstract available


  206. COSTA KD
    Decellularized Scaffold Hydrogel Materials for MI Treatment: Could "The Matrix" Really Be the Future?
    J Am Coll Cardiol. 2016;67:1087-90.
    PubMed     Text format    


  207. WASSENAAR JW, Gaetani R, Garcia JJ, Braden RL, et al
    Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
    J Am Coll Cardiol. 2016;67:1074-86.
    PubMed     Text format     Abstract available


  208. FONAROW GC, Ziaeian B
    Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation.
    J Am Coll Cardiol. 2016;67:1070-3.
    PubMed     Text format    


  209. VEST AR, Schauer PR, Young JB
    Failure and Fatness: Could Surgical Management of Obesity Reduce Heart Failure Hospitalizations?
    J Am Coll Cardiol. 2016;67:904-6.
    PubMed     Text format    


  210. SHIMADA YJ, Tsugawa Y, Brown DF, Hasegawa K, et al
    Bariatric Surgery and Emergency Department Visits and Hospitalizations for Heart Failure Exacerbation: Population-Based, Self-Controlled Series.
    J Am Coll Cardiol. 2016;67:895-903.
    PubMed     Text format     Abstract available


  211. RADFORD MJ
    Does Public Reporting Improve Care?
    J Am Coll Cardiol. 2016;67:973-5.
    PubMed     Text format    


  212. DEVORE AD, Hammill BG, Hardy NC, Eapen ZJ, et al
    Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data.
    J Am Coll Cardiol. 2016;67:963-72.
    PubMed     Text format     Abstract available


    February 2016
  213. KETEYIAN SJ, Patel M, Kraus WE, Brawner CA, et al
    Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure.
    J Am Coll Cardiol. 2016;67:780-9.
    PubMed     Text format     Abstract available


  214. FRANCIS GS, Thenappan T
    The End Is Near... Do We Know Everything About Cardiopulmonary Exercise Testing in HF Patients?
    J Am Coll Cardiol. 2016;67:790-2.
    PubMed     Text format    


  215. KOSMALA W, Rojek A, Przewlocka-Kosmala M, Mysiak A, et al
    Contributions of Nondiastolic Factors to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2016;67:659-70.
    PubMed     Text format     Abstract available


  216. BORLAUG BA
    Is HFpEF One Disease or Many?
    J Am Coll Cardiol. 2016;67:671-3.
    PubMed     Text format    


  217. MERCHANT FM, Quest T, Leon AR, El-Chami MF, et al
    Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients.
    J Am Coll Cardiol. 2016;67:435-44.
    PubMed     Text format     Abstract available


    January 2016
  218. FRANCIS GS, Felker GM, Tang WH
    A Test in Context: Critical Evaluation of Natriuretic Peptide Testing in Heart Failure.
    J Am Coll Cardiol. 2016;67:330-7.
    PubMed     Text format     Abstract available


  219. RAME JE
    Metabolic Staging in Human Heart Failure: Circulating Acylcarnitines and the Failing Heart's Energetic Signature.
    J Am Coll Cardiol. 2016;67:300-2.
    PubMed     Text format    


  220. AHMAD T, Kelly JP, McGarrah RW, Hellkamp AS, et al
    Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.
    J Am Coll Cardiol. 2016;67:291-9.
    PubMed     Text format     Abstract available


  221. MOON JC, Treibel TA, Schelbert EB
    Myocardial Fibrosis in Hypertensive Heart Failure: Does Quality Rather Than Quantity Matter?
    J Am Coll Cardiol. 2016;67:261-3.
    PubMed     Text format    


  222. LOPEZ B, Ravassa S, Gonzalez A, Zubillaga E, et al
    Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
    J Am Coll Cardiol. 2016;67:251-60.
    PubMed     Text format     Abstract available


  223. GARDIN JM
    The Value of Left Ventricular Relative Wall Thickness in Predicting Ventricular Arrhythmia and Related Death.
    J Am Coll Cardiol. 2016;67:313-5.
    PubMed     Text format    


  224. BITON Y, Goldenberg I, Kutyifa V, Baman JR, et al
    Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2016;67:303-12.
    PubMed     Text format     Abstract available


    December 2015
  225. RISUM N, Kisslo J, Gorcsan J 3rd, Sogaard P, et al
    Reply: Echocardiographic Substrate for Biventricular Pacing.
    J Am Coll Cardiol. 2015;66:2915-6.
    PubMed     Text format    


  226. LIM HS
    Echocardiographic Substrate for Biventricular Pacing.
    J Am Coll Cardiol. 2015;66:2914-5.
    PubMed     Text format    


  227. GRODIN JL, Testani JM, Tang WH
    Reply: Hypochloremia in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2015;66:2683-2684.
    PubMed     Text format    


  228. LIM HS
    Hypochloremia in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2015;66:2682-2683.
    PubMed     Text format    


  229. CLELAND JG, Mareev Y
    CRT for Heart Failure and ESRD: More Trials or More Thought Needed?
    J Am Coll Cardiol. 2015;66:2630-2632.
    PubMed     Text format    


  230. AGOSTONI P, Contini M, Vignati C, Del Torto A, et al
    Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure Patients.
    J Am Coll Cardiol. 2015;66:2571-2.
    PubMed     Text format    


  231. KOCH WJ, Cannavo A
    Eating Away at Heart Failure.
    J Am Coll Cardiol. 2015;66:2534-5.
    PubMed     Text format    


  232. PEREZ MV, Pavlovic A, Shang C, Wheeler MT, et al
    Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure.
    J Am Coll Cardiol. 2015;66:2522-33.
    PubMed     Text format     Abstract available


  233. KISHI S, Teixido-Tura G, Venkatesh BA, Lima JA, et al
    Reply: Speckle-Tracking Echocardiography-Derived Longitudinal Dysfunction: A Novel Starting Point of the Hypertensive Patient's Journey Toward Heart Failure.
    J Am Coll Cardiol. 2015;66:2473.
    PubMed     Text format    


  234. GALDERISI M, Trimarco B
    Speckle-Tracking Echocardiography-Derived Longitudinal Dysfunction: A Novel Starting Point of the Hypertensive Patient's Journey Toward Heart Failure.
    J Am Coll Cardiol. 2015;66:2472.
    PubMed     Text format    


    November 2015
  235. ENGELHARDT S, Sassi Y
    MicroRNA Augmentation of Bone Marrow-Derived Cell Therapy.
    J Am Coll Cardiol. 2015;66:2227-9.
    PubMed     Text format    


  236. JOLADARASHI D, Srikanth Garikipati VN, Thandavarayan RA, Verma SK, et al
    Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.
    J Am Coll Cardiol. 2015;66:2214-26.
    PubMed     Text format     Abstract available


  237. JOLICOEUR EM, Dunning A, Castelvecchio S, Dabrowski R, et al
    Importance of Angina in Patients With Coronary Disease, Heart Failure, and Left Ventricular Systolic Dysfunction: Insights From STICH.
    J Am Coll Cardiol. 2015;66:2092-100.
    PubMed     Text format     Abstract available


  238. GESKE JB, Gersh BJ
    Angina in revascularization of ischemic cardiomyopathy: the whole quilt, or just a STICH?
    J Am Coll Cardiol. 2015;66:2101-3.
    PubMed     Text format    


  239. DEC GW
    LCZ696 (sacubitril/valsartan): can we predict who will benefit?
    J Am Coll Cardiol. 2015;66:2072-4.
    PubMed     Text format    


  240. SIMPSON J, Jhund PS, Silva Cardoso J, Martinez F, et al
    Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.
    J Am Coll Cardiol. 2015;66:2059-71.
    PubMed     Text format     Abstract available


  241. CALORE M, De Windt LJ
    Longing for Naiades in Heart Failure.
    J Am Coll Cardiol. 2015;66:2016-8.
    PubMed     Text format    


    October 2015
  242. ASGAR AW, Mack MJ, Stone GW
    Reply: Secondary Mitral Regurgitation.
    J Am Coll Cardiol. 2015;66:1947.
    PubMed     Text format    


  243. BOLTWOOD CM JR, Shah PM
    Secondary Mitral Regurgitation.
    J Am Coll Cardiol. 2015;66:1946-7.
    PubMed     Text format    


  244. ESTEP JD, Starling RC, Horstmanshof DA, Milano CA, et al
    Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.
    J Am Coll Cardiol. 2015;66:1747-61.
    PubMed     Text format     Abstract available


  245. KATZ SD, Parikh CR
    Reverse Left Ventricular Remodeling After Kidney Transplantation: Unraveling the Complex Autointoxication of Uremia.
    J Am Coll Cardiol. 2015;66:1788-90.
    PubMed     Text format    


  246. HAWWA N, Shrestha K, Hammadah M, Yeo PS, et al
    Reverse Remodeling and Prognosis Following Kidney Transplantation in Contemporary Patients With Cardiac Dysfunction.
    J Am Coll Cardiol. 2015;66:1779-87.
    PubMed     Text format     Abstract available


  247. BRUCE CR, Blumenthal-Barby JS, Meyers D
    Benefits and Challenges of Early Introduction of Left Ventricular Assist Device Placement: A Patient-Centered Perspective.
    J Am Coll Cardiol. 2015;66:1762-5.
    PubMed     Text format    


  248. PAULUS WJ, van Heerebeek L
    Ancient Gunpowder and Novel Insights Team Up Against Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2015;66:1683-6.
    PubMed     Text format    


  249. BORLAUG BA, Koepp KE, Melenovsky V
    Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2015;66:1672-82.
    PubMed     Text format     Abstract available


    September 2015
  250. ZOTTER-TUFARO C, Duca F, Kammerlander AA, Koell B, et al
    Diastolic Pressure Gradient Predicts Outcome in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2015;66:1308-10.
    PubMed     Text format    


  251. VERMOND RA, Geelhoed B, Verweij N, Tieleman RG, et al
    Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    J Am Coll Cardiol. 2015;66:1000-7.
    PubMed     Text format     Abstract available


  252. KOWEY PR, Robinson VM
    Observing the Obvious.
    J Am Coll Cardiol. 2015;66:1008-10.
    PubMed     Text format    


    August 2015
  253. ADES PA
    Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Awaiting the Uptick.
    J Am Coll Cardiol. 2015;66:927-9.
    PubMed     Text format    


  254. GOLWALA H, Pandey A, Ju C, Butler J, et al
    Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure: Findings From Get With The Guidelines-Heart Failure Registry.
    J Am Coll Cardiol. 2015;66:917-26.
    PubMed     Text format     Abstract available


  255. LANIER GM
    New Insights and Clarity for Peripartum Heart Failure and Recovery in the Modern Era.
    J Am Coll Cardiol. 2015;66:915-6.
    PubMed     Text format    


  256. O'CONNOR CM, Ahmad T
    The Role of Sodium and Chloride in Heart Failure: Does It Take Two to Tango?
    J Am Coll Cardiol. 2015;66:667-9.
    PubMed     Text format    


  257. GRODIN JL, Simon J, Hachamovitch R, Wu Y, et al
    Prognostic Role of Serum Chloride Levels in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2015;66:659-66.
    PubMed     Text format     Abstract available


  258. GILL EA, Poole JE
    Will the Real Left Bundle Branch Block Please Stand Up?
    J Am Coll Cardiol. 2015;66:642-4.
    PubMed     Text format    


  259. PATTON KK
    Ejection Fraction Improvement After Primary Prevention Defibrillator Implantation: How Much Is Enough?
    J Am Coll Cardiol. 2015;66:532-4.
    PubMed     Text format    


  260. ZHANG Y, Guallar E, Blasco-Colmenares E, Butcher B, et al
    Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.
    J Am Coll Cardiol. 2015;66:524-531.
    PubMed     Text format     Abstract available


    July 2015
  261. SANTANGELI P, Marchlinski FE
    Ventricular Ectopy as a Modifiable Risk Factor for Heart Failure and Death: "Deja Vu All Over Again" May Be a Good Thing.
    J Am Coll Cardiol. 2015;66:110-2.
    PubMed     Text format    


  262. DUKES JW, Dewland TA, Vittinghoff E, Mandyam MC, et al
    Ventricular Ectopy as a Predictor of Heart Failure and Death.
    J Am Coll Cardiol. 2015;66:101-9.
    PubMed     Text format     Abstract available


  263. KITAKAZE M
    Trends in Characteristics of CVD in Asia and Japan: The Importance of Epidemiological Studies and Beyond.
    J Am Coll Cardiol. 2015;66:196-8.
    PubMed     Text format    


  264. TANG WH, Hazen SL
    Reply: Trimethylamine-N-Oxide and Heart Failure.
    J Am Coll Cardiol. 2015;66:96-7.
    PubMed     Text format    


  265. MCCARTY MF, DiNicolantonio JJ
    Trimethylamine-N-Oxide and Heart Failure.
    J Am Coll Cardiol. 2015;66:94-6.
    PubMed     Text format    


  266. FELKER GM, Metra M, Teerlink JR
    Reply: Mode of Death Prevention by Serelaxin.
    J Am Coll Cardiol. 2015;66:99.
    PubMed     Text format    


  267. HENRY BL, Schwartzman DS, Salama G
    Mode of Death Prevention by Serelaxin.
    J Am Coll Cardiol. 2015;66:98-9.
    PubMed     Text format    


    June 2015
  268. ALLEN LA, Fonarow GC, Simon DN, Thomas LE, et al
    Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
    J Am Coll Cardiol. 2015;65:2691-8.
    PubMed     Text format     Abstract available


  269. FORMAN DE, Sanderson BK, Josephson RA, Raikhelkar J, et al
    Heart Failure as a Newly Approved Diagnosis for Cardiac Rehabilitation: Challenges and Opportunities.
    J Am Coll Cardiol. 2015;65:2652-9.
    PubMed     Text format     Abstract available


  270. MANCINI D, Colombo PC
    Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant.
    J Am Coll Cardiol. 2015;65:2542-55.
    PubMed     Text format     Abstract available


  271. HUSAIN-SYED F, McCullough PA, Birk HW, Renker M, et al
    Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach.
    J Am Coll Cardiol. 2015;65:2433-48.
    PubMed     Text format     Abstract available


  272. LALA A, Mentz RJ
    A call for collaboration: the evolving heart failure apprenticeship network.
    J Am Coll Cardiol. 2015;65:2348-51.
    PubMed     Text format    


  273. PINNEY SP
    RESPONSE: Research Networks=Shared Sacrifice and Success.
    J Am Coll Cardiol. 2015;65:2350-1.
    PubMed     Text format    


    May 2015
  274. DIAKOS NA, Selzman CH, Stehlik J, Sachse FB, et al
    Reply: does size matter? In search of a physiological definition of myocardial atrophy.
    J Am Coll Cardiol. 2015;65:2156-7.
    PubMed     Text format    


  275. TERRACCIANO CM, Navaratnarajah M, Bello SO, Ibrahim M, et al
    Does size matter? In search of a physiological definition of myocardial atrophy.
    J Am Coll Cardiol. 2015;65:2154-6.
    PubMed     Text format    


  276. MARON BJ, Rowin EJ, Casey SA, Link MS, et al
    Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    J Am Coll Cardiol. 2015;65:1915-28.
    PubMed     Text format     Abstract available


    April 2015
  277. WILLIAM DEC G
    Response: advanced heart failure care: Aequanimitas and compassion are both essential.
    J Am Coll Cardiol. 2015;65:1483.
    PubMed     Text format    


  278. AHMAD T
    Wherein lies the balance between caring and detachment?
    J Am Coll Cardiol. 2015;65:1481-2.
    PubMed     Text format    


    March 2015
  279. GIL-CAYUELA C, Rivera M, Ortega A, Tarazon E, et al
    RNA sequencing analysis identifies new human collagen genes involved in cardiac remodeling.
    J Am Coll Cardiol. 2015;65:1265-7.
    PubMed     Text format    


  280. GERSHLICK AH, Khan JN, Kelly DJ, Greenwood JP, et al
    Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease: The CvLPRIT Trial.
    J Am Coll Cardiol. 2015;65:963-72.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: